IDHC Share Price Performance
US$0.65
0.29 (80.56%)
18.9% undervalued intrinsic discount
US$0.80
Fair Value
Price US$0.65
AnalystConsensusTarget US$0.80
AnalystLowTarget US$0.71
AnalystHighTarget US$0.91
Fair ValueUS$0.80
Share Pricen/a
Integrated Diagnostics Holdings plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 72 Fair Values set on narratives written by author
IDHC Community Narratives
AN
Fair Value US$0.8 18.9% undervalued intrinsic discount
Acquisition And Branch Expansion Will Unlock Middle East Opportunities
4users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
AN
Fair Value US$0.71 7.8% undervalued intrinsic discount
Egypt, Nigeria Risks Will Curtail Prospects Yet Saudi Will Emerge
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$0.91 28.6% undervalued intrinsic discount
Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Egypt, Nigeria Risks Will Curtail Prospects Yet Saudi Will Emerge
Key Takeaways Heavy geographic concentration heightens vulnerability to local risks, while slow diversification tempers the benefits of expanding into new markets. Rising digital healthcare adoption and intensifying competition threaten core lab volumes and margin growth, challenging the long-term traditional business model.Read more
69
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$0.71
7.8% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
19.57% p.a.
Profit Margin
20.73%
Future PE
9.15x
Price in 2029
US$0.87
Acquisition And Branch Expansion Will Unlock Middle East Opportunities
Key Takeaways Strategic repricing and acquisition initiatives in Saudi Arabia position IDH for increased revenue growth and margin improvements as operations scale. Expansion of new branches in Egypt and focus on radiology in Saudi Arabia poised to capture market share and boost earnings.Read more
349
users have viewed this narrative4users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
AN
US$0.8
18.9% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
17.27% p.a.
Profit Margin
20.37%
Future PE
11.07x
Price in 2029
US$0.99
Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery
Key Takeaways Scale improvements and easing macro pressures in key markets are driving stronger-than-expected margin expansion and greater financial flexibility for broader growth. Strategic digital, home-based, and advanced diagnostic service expansion positions the company for accelerated revenue growth and long-term leadership across targeted regions.Read more
45
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
US$0.91
28.6% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
16.89% p.a.
Profit Margin
19.49%
Future PE
14.72x
Price in 2028
US$1.11
Trending Discussion
Recently Updated Narratives
AN
IDHC: Fair Value View Will Reflect Slightly Stronger Margins And Earnings Multiple
Fair Value: US$0.71 7.8% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
IDHC: Higher Margins And Lower Future P/E Will Support Upside Potential
Fair Value: US$0.8 18.9% undervalued intrinsic discount
35 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery
Fair Value: US$0.91 28.6% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Integrated Diagnostics Holdings plc Key Details
About IDHC
- Founded
- 1979
- Employees
- 6309
- CEO
- WebsiteView website
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.
